Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$613.69 USD
-6.56 (-1.06%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $613.82 +0.13 (0.02%) 5:16 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Average Brokerage Rating
Current ABR | 1.48 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 22 |
Average Target Price | $648.60 |
LT Growth Rate | 9.30% |
Industry | Medical - Instruments |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | 5.25 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 14 | 13 | 13 | 13 |
Buy | 3 | 3 | 3 | 3 | 3 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.48 | 1.50 | 1.52 | 1.52 | 1.52 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/16/2024 | UBS | Dan Leonard | Not Available | Strong Buy |
8/28/2024 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/25/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
7/25/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
7/25/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
7/24/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
7/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/16/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
7/2/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
6/17/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/25/2024 | Not Identified | Not Identified | Hold | Hold |
3/18/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1/8/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.